Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022355054> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W2022355054 endingPage "25" @default.
- W2022355054 startingPage "317" @default.
- W2022355054 abstract "Angiotensin converting enzyme (ACE, kininase II) is an endothelial luminal ectoenzyme. The majority of ACE has been found on the pulmonary capillary endothelium (PCE). Pulmonary capillary endothelium-bound (PCEB)-ACE has been extensively studied by means of indicator dilution techniques in animals and man. We have recently developed and applied methodologies for assaying pulmonary capillary endothelium-bound (PCEB) angiotensin converting enzyme (ACE) activity in man. This article provides a summary of our studies in human subjects utilizing similar methodology. Trace amounts of the specific ACE substrate, (3)H-benzoyl-Phe-Ala-Pro ((3)H-BPAP; 40 microCi or 2 nmol), was injected as a bolus into the subclavian vein of patients and immediately blood was withdrawn from a radial arterial catheter. Plasma concentrations of surviving substrate and product ((3)H-benzoyl-Phe) were estimated and BPAP utilization was calculated during a single transpulmonary passage. To investigate the PCE in this manner we tested the hypothesis that PCEB-ACE is depressed in patients diagnosed with acute lung injury and estimated interaction of an ACE inhibitor (enalaprilat) with PCE in human subjects. An inverse correlation was found between the pulmonary endothelium-bound ACE activity (v) and the lung injury score (r=0.379; p<0.01). Similarly, an inverse correlation was found between the pulmonary capillary perfusion index (CPI) and the lung injury score (r=0.284, p<0.05). PCEB-ACE activity in the group of patients with mild lung injury was significantly different from the group of control patients (0.44 +/- 0.048 vs. 1.15 +/- 0.05; p<0.01). Trace amounts (1.5 microg/kg) of enalaprilat had no significant effect on mean arterial pressure (91 +/- 6 vs. 84 +/- 7 vs. 88 +/- 6 mmHg for T(1), T(2) and T(3), respectively), but significantly decreased PCEB-ACE activities. When normalized to pre-drug (T(1)) activity levels, enalaprilat inhibited PCEB and SE ACE activity at T(2) by 74 +/- 6 and 68 +/- 6%, respectively. PCEB-ACE measurements can be used in clinical practice for estimating PCE functions and can provide new insight into the physiology of the pulmonary circulation." @default.
- W2022355054 created "2016-06-24" @default.
- W2022355054 creator A5001400031 @default.
- W2022355054 creator A5051431561 @default.
- W2022355054 creator A5078902157 @default.
- W2022355054 date "2002-03-01" @default.
- W2022355054 modified "2023-10-10" @default.
- W2022355054 title "Endothelial function studies in pulmonary vascular disease: determination of angiotensin converting enzyme activity in humans (review)." @default.
- W2022355054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12389582" @default.
- W2022355054 hasPublicationYear "2002" @default.
- W2022355054 type Work @default.
- W2022355054 sameAs 2022355054 @default.
- W2022355054 citedByCount "2" @default.
- W2022355054 crossrefType "journal-article" @default.
- W2022355054 hasAuthorship W2022355054A5001400031 @default.
- W2022355054 hasAuthorship W2022355054A5051431561 @default.
- W2022355054 hasAuthorship W2022355054A5078902157 @default.
- W2022355054 hasConcept C113045295 @default.
- W2022355054 hasConcept C126322002 @default.
- W2022355054 hasConcept C134018914 @default.
- W2022355054 hasConcept C146957229 @default.
- W2022355054 hasConcept C164705383 @default.
- W2022355054 hasConcept C185592680 @default.
- W2022355054 hasConcept C27016395 @default.
- W2022355054 hasConcept C2776992346 @default.
- W2022355054 hasConcept C2777714996 @default.
- W2022355054 hasConcept C2777814262 @default.
- W2022355054 hasConcept C2779611605 @default.
- W2022355054 hasConcept C71924100 @default.
- W2022355054 hasConcept C75603125 @default.
- W2022355054 hasConcept C84393581 @default.
- W2022355054 hasConceptScore W2022355054C113045295 @default.
- W2022355054 hasConceptScore W2022355054C126322002 @default.
- W2022355054 hasConceptScore W2022355054C134018914 @default.
- W2022355054 hasConceptScore W2022355054C146957229 @default.
- W2022355054 hasConceptScore W2022355054C164705383 @default.
- W2022355054 hasConceptScore W2022355054C185592680 @default.
- W2022355054 hasConceptScore W2022355054C27016395 @default.
- W2022355054 hasConceptScore W2022355054C2776992346 @default.
- W2022355054 hasConceptScore W2022355054C2777714996 @default.
- W2022355054 hasConceptScore W2022355054C2777814262 @default.
- W2022355054 hasConceptScore W2022355054C2779611605 @default.
- W2022355054 hasConceptScore W2022355054C71924100 @default.
- W2022355054 hasConceptScore W2022355054C75603125 @default.
- W2022355054 hasConceptScore W2022355054C84393581 @default.
- W2022355054 hasIssue "3" @default.
- W2022355054 hasLocation W20223550541 @default.
- W2022355054 hasOpenAccess W2022355054 @default.
- W2022355054 hasPrimaryLocation W20223550541 @default.
- W2022355054 hasRelatedWork W1966732677 @default.
- W2022355054 hasRelatedWork W1967842519 @default.
- W2022355054 hasRelatedWork W2022355054 @default.
- W2022355054 hasRelatedWork W2035883323 @default.
- W2022355054 hasRelatedWork W2118279423 @default.
- W2022355054 hasRelatedWork W2149729817 @default.
- W2022355054 hasRelatedWork W2273726813 @default.
- W2022355054 hasRelatedWork W2317802089 @default.
- W2022355054 hasRelatedWork W2380571071 @default.
- W2022355054 hasRelatedWork W2411950089 @default.
- W2022355054 hasVolume "9" @default.
- W2022355054 isParatext "false" @default.
- W2022355054 isRetracted "true" @default.
- W2022355054 magId "2022355054" @default.
- W2022355054 workType "article" @default.